Kanagawa, Japan

Kohsuke Asoh

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2015-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohsuke Asoh. Retrieved from https://idiyas.com/inventor/kohsuke-asoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kohsuke Asoh: Innovator in ALK Inhibitor Research

Introduction

Kohsuke Asoh is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Kohsuke Asoh holds 2 patents related to tetracyclic compounds. These compounds are represented by a general formula and are recognized for their utility as ALK inhibitors. They are particularly useful in the prophylaxis or treatment of diseases associated with abnormalities in ALK, such as cancer, cancer metastasis, depression, and cognitive function disorders.

Career Highlights

Asoh is currently employed at Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His work focuses on innovative drug development aimed at improving patient outcomes in various medical conditions.

Collaborations

Kohsuke Asoh collaborates with esteemed colleagues, including Kazutomo Kinoshita and Noriyuki Furuichi. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Kohsuke Asoh's contributions to the field of ALK inhibitors highlight his role as a key innovator in medicinal chemistry. His work continues to pave the way for advancements in the treatment of serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…